Pathology of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation

Pediatric Pathology and Laboratory Medicine

Volumn 17, Issue 3, 1997, Pages 427-447

  Tyni, Tuna ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

fatty acid desaturase deficiency; inborn error of metabolism; kidney pathology; lipid metabolism; liver pathology; myocardium pathology; neuropathology

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE;

ARTICLE; CARDIOMEGALY; ENZYME DEFICIENCY; ESSENTIAL FATTY ACID DEFICIENCY; GENE MUTATION; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; LIPID OXIDATION; NEWBORN; PRENATAL DIAGNOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL;

3-HYDROXYACYL COA DEHYDROGENASES; BRAIN; FATTY ACIDS; FEMALE; HOMOZYGOTE; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY; LIPID METABOLISM, INBORN ERRORS; LIVER; MALE; MUSCLE, SKELETAL; MYOCARDIUM; OXIDATION-REDUCTION; POINT MUTATION; PREGNANCY;

EID: 0031000397     PISSN: 10771042     EISSN: None     Source Type: Journal    
DOI: 10.1080/107710497174732     Document Type: Article

References (49)

1. Carpenter K, Pollitt RJ, Middleton B, Human liver long-chain 3-hydroxyacyl-coenzyme A dehydrogenase is a multifunctional membrane-bound beta-oxidation enzyme of mitochondria, Biochem Biophys Res Commun 1992;183:443-8.
2. Uchida Y, Izai K, Orii T, Hashimoto T, Novel fatty acid β-oxidation enzymes in rat liver mitochondria, II. Purification and properties of enoyl-coenzyme A (CoA) hydrataseβ-hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase trifunctional protein. J Biol Chem 1992;267:1034-41.
3. Kamijo T, Aoyama T, Komiyama A, Hashimoto T, Structural analysis of cDNAs for subunits of human mitochondria! fatty acid β-oxidation trifunctional protein, Biochem Biophys Res Commun 1994;199: 818-25.
4. Roe CR, Coates PM, Mitochondrial fatty acid oxidation disorders, In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York: McGraw-Hill, 1995;1501-34.
5. Dionisi Vici C, Burlina A, Bertini E, et al, Progressive neuropathy and recurrent myoglobinuria in a child with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency, J Pediatr 1991;! 18:744-6.
6. Moore R, Glasgow JFT, Bingham MA, et al, Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency-diagnosis, plasma carnitine fractions and management in a further patient, EurJ Pediatr 1993; 152:433-6.
7. Treem WR, Rinaldo P, Hale DE, et al, Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency, Hepatology 1994;19:339-45.
8. von Döbeln U, Nyberg G, Hagenfeldt L, Clinical symptoms and dietary management of 3-hydroxyacylCoA-dehydrogenase deficiency, Presented at the Sixth International Congress of Inborn Errors of Metabolism, Milan, 1994.
9. Duran M, Wanders R, dejagerj, et al, 3-Hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacylcoenzyme A dehydrogenase deficiency associated with sudden neonatal death: Protective effect of medium-chain triglycéride treatment. EurJ Pediatr 1991;150:190-5.
10. FryburgJS, Pelegano JP, Bennett MJ, Bebin EM, Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase (L-CHAD) deficiency in a patient with the Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet 1994;52:97-102.
11. Hale D, Thorpe C, Braat K, el al, The L-3-hydroxyacyl-CoA dehydrogenase deficiency. In: Tanaka K, Coates PM, eds. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects. New York: Alan RLiss, 1990;503-10.
12. Jackson S, Bartlett K, Land J, et al, Long-chain 3-hydroxyacyl-coA dehydrogenase deficiency. Pediatr Resl991;29:406-ll.
13. Przyrembel H, Jakobs C, IJlst L, De KlerkJ, Wanders R, Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 1991; 14:674-80.
14. Rocchiccioli F, Wanders RJA, Aubourg P, et al, Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: A cause of lethal myopathy and cardiomyopathy in early childhood. Pediatr Res 1990;28: 657-62.
15. van Maldergem L, Bachy A, Tuerlinckx D, et al, Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency presenting as hepatic cirrhosis in two siblings. Presented at the Sixth International Congress of Inborn Errors of Metabolism, Milan, 1994.
16. Ribes A, Riudor E, Navarro C, Boronat M, Marti M, Hale DE, Fatal outcome in a patient with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 1992; 15:278-9.
17. Wanders R, Duran M, IJlst L, et al, Sudden infant death and long-chain 3-hydroxyacyl-CoA dehydrogenase. Lancet 1989;2:52-3.
18. Wanders RJA, IJlst L, van Gennip AH, et al, Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: Identification of a new inborn error of mitochondria! fatty acid β-oxidation. J Inherit Metab Dis 1990;13:311-14.
19. Wanders R, IJlst L, Duran M, et al, Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: Different clinical expression in three unrelated patients. J Inherit Metab Dis 1991; 14:325-8.
20. Sewell AC, Bender SW, Wirth S, Mûnterfering H, IJlst L, Wanders RJA, Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: A severe fatty acid oxidation disorder. Eur ( Pediatr 1994; 153:745-50.
21. Bertini E, Dionisi-Vici C, Garavaglia B, et al, Peripheral sensory-motor polyneuropathy, pigmentary retinopathy, and fatal cardiomyopathy in long-chain 3-hydroxy-acyl-CoA dehydrogenase deficiency. EurJ Pediatr 1992;151:121-6.
22. Jackson S, Singh Kler R, Bartlett K, et al, Combined enzyme defect of mitochondrial fatty acid oxidation. J Clin Invest 1992;90:1219-25.
23. Wanders RJA, IJlst L, Poggi F, et al, Human trifunctional protein deficiency: A new disorder of mitochondrial fatty acid β-oxidation. Biochem Biophys Res Commun 1992; 188:1139-45.
24. Brackett JC, Sims HF, Rinaldo P, et al, Two a subunit donor splice site mutations cause human trifunctional protein deficiency.J Clin Invest 1995;95:2076-82.
25. IJlst L, Wanders RJA, Ushikubo S, Kamijo T, Hashimoto T, Molecular basis of long-chain 3-hydroxyacylCoA dehydrogenase deficiency: Identification of the major disease-causing mutation in the alphasubunitof the mitochondrial trifunctional protein. Biochim Biophys Acta 1994;1215:347-50.
26. IJlst L, Ushikubo S, Kamijo T, et al, Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: High frequency of the G1528C mutation with no apparent correlation with the clinical phenotype. J Inherit Metab Dis 1995; 18:241-4.
27. IJlst L, RuiterJPN, Jakobs M, Hoovers JMN, Hashimoto T, Wanders RJA, Long-chain 3-hydroxyacylCoA dehydrogenase deficiency: Identification of mutations using a new method applicable to genomic DNA and localisation of the gene for the a-subunit to 2p23.3-24.1. Presented at the 33rd Annual Symposium of SSIEM, Toledo, 1995.
28. Hagenfeldt L, von Döbeln U, Holme E, et al, 3-Hydroxydicarboxylic aciduria-a fatty acid oxidation defect with severe prognosis. J Pediatr 1990;! 16:387-92.
29. Tyni T, Palotie A, Viinikka L, et al, Long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency with the G1528C mutation: Clinical presentation of 13 patients. J Pediatr, 1997;130:67-76.
30. Mikkola H, Syrjälä M, Rasi V, et ai, Deficiency in the A-subunit of coagulation factor XIII: Two novel point mutations demonstrate different effects of transcript levels. Blood 1994;84:517-25.
31. Syvänen A, Aalto-Setälä K, Harju L, Kontula K, Söderlund H, A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. Genomics 1990;8:684-90.
32. Venizelos N, IJlst L, Wanders RJA, Hagenfeldt L, β-Oxidation enzymes in fibroblasts from patients with 3-hydroxydicarboxylic aciduria. Pediatr Res 1994;36:111-14.
33. Dubowitz V, Muscle Biopsy. A Practical Approach. 2nd ed. London: Baillière Tindall, 1985.
34. Tyni T, Majander A, Kalimo H, Rapola J, Pihko H, Pathology of skeletal muscle and impaired respiratory chain function in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency with the G1528C mutation.] Neuromusc Disord. 1996;6:327-337.
35. Tourna EH, Charpentier C, Medium chain acyl-CoA dehydrogenase deficiency. Arch Dis Child 1992;67:142-5.
36. lafolla AK, Thompson RJJ, Roe CR, Medium-chain acyl-coenzyme A dehydrogenase deficiency: Clinical course in 120 affected children.] Pediatr 1994;124:409-15.
37. Singh AK, Yoshida Y, Garvin AJ, Singh I, Effect of fatty acids and their derivatives on mitochondrial structures. J Exp Pathol 1989;4:9-15.
38. Aoyama T, Souri M, Ushikubo S, et al, Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients. J Clin Invest 1995;95:2465-73.
39. Catzeflis C, Bachmann C, Hale DE, et al, Early diagnosis and treatment of neonatal medium-chain acyl-CoA dehydrogenase deficiency: Report of two siblings. EurJ Pediatr 1990; 149:577-81.
40. Amendt BA, Greene C, Sweetman L, et al, Short chain acyl-CoA dehydrogenase deficiency: Clinical and biochemical studies in two patients. Clin Invest 1987;79:1303-9.
41. Bhala A, Willi SM, Rinaldo P, Bennett MJ, Schmidt-Sommerfeld E, Hale DE, Clinical and biochemical characterization of short-chain acyl-coenzyme A dehydrogenase deficiency.] Pediatr 1995; 126:910-15.
42. Böhm N, Uy J, Kieβling M, Lehnert W, Multiple acyl-coA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two newborn brothers. II. Morphology and pathogenesis. EurJ Pediatr 1982;139:60-5.
43. North KN, Hoppel CL, De Girolami U, Kozakewich HPW, Korson MS, Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys. J Pediatr 1995;127:414-20.
44. Stockier S, Radner H, Karpf EF, Hauer A, Ebner F, Symmetric hypoplasia of the temporal cerebral lobes in an infant with glutaric aciduria type II (multiple acyl-coenzyme A dehydrogenase deficiency). J Pediatr 1994;124:601-4.
45. Sparaco M, BonillaE, DiMauroS, PowersJM, Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects.] Neuropathol Exp Neurol 1993;52:1-10.
46. Oldfors A, Fyhr I-M, Holme E, Larsson N-G, Tulinius M, Neuropathology in Kearns-Sayre syndrome. Acta Neuropathol (Berl) 1990;80:541-6.
47. Partin JC, Partin JS, Schubert WK, McLaurin RL, Brain ultrastructure in Reye's syndrome (encephalopathy and fatty alteration of the viscera).] Neuropathol Exp Neurol 1975;34:425-44.
48. Roe CR, Coates PM, Acyl-CoA dehydrogenase deficiencies. In: Scriver CR, Beaudet AI., Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York: McGraw-Hill, 1989;889-914.
49. Auestad N, Korsak RA, Morrow JW, Edmond], Fatty acid oxidation and ketogenesis by astrocytes in primär)'culture. J Neurochem 1991;56:1376-86.